Skip to main content

Table 1 Patient baseline characteristics, comorbidities and duration of surgery

From: Impact of brief prewarming on anesthesia-related core-temperature drop, hemodynamics, microperfusion and postoperative ventilation in cytoreductive surgery of ovarian cancer: a randomized trial

 

prewarm n=24

standard n= 23

Age (Years, mean±SD)

54,4

(±11,7)

61,3

(12,1)

Weight (kg, mean±SD)

73,6

(17,6)

67,8

(10,3)

Height (cm, mean±SD)

167

(4,9)

164,0

(6,1)*

BMI (mean±SD)

26,3

(5,8)

25,4

(4,1)

FIGO stage (n, %)

 I

1

(4)

0

(0)

 II

0

(0)

0

(0)

 III

17

(68)

14

(64)

 IV

5

(20)

4

(18)

Residual tumor after surgery (n, %):

 0 cm

18

(72)

17

(77)

 0-1 cm

5

(20)

4

(18)

 1-2 cm

1

(4)

1

(5)

 >2 cm

2

(8)

0

(0)

Preoperative fasting (Liquids in hrs, mean±SD)

11,3

(4,2)

11,6

(3,8)

Preoperative fasting (Solid in hrs, mean±SD)

16,7

(4,7)

16,2

(4,8)

Coronary artery disease (n,%)

0

(0)

1

(4,4)

Heart failure (n,%)

0

(0)

0

(0)

Diabetes mellitus (n,%)

1

(4,2)

1

(4,4)

Hypothyroidism (n,%)

1

(4,2)

4

(17.4)

Renal failure (n,%)

0

(0)

1

(4,4)

Arterial hypertension (n,%)

5

(20,8)

7

(30,4)

Peripheral arterial vascular disease (n,%)

1

(4,2)

1

(4,4)

COPD (n,%)

1

(4,2)

1

(4,4)

Asthma (n,%)

3

(12,5)

2

(8,7)

Thrombosis (n,%)

3

(12,5)

1

(4,4)

Hyperthyroidism (n,%)

1

(4,2)

1

(4,4)

Nicotine abuse (n,%)

0

(0)

1

(4,4)

Hyperlipoproteinemia (n,%)

0

(0)

3

(13)

ASA Classification (n,%):

 1

4

(16,7)

3

(13)

 2

12

(50)

14

(60,9)

 3

8

(33,3)

6

(26,1)

Duration of surgery§ (min, mean ± SD)

334

±114

364

±134

  1. *p < 0.05; § incision to suture; SD Standard deviation, BMI body mass index, FIGO International Federation of Gynecology and Obstetrics, COPD chronic obstructive pulmonary disease, ASA American Society of Anesthesiologists